Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 22;20(12):3062.
doi: 10.3390/ijms20123062.

Concentration of Fe(3+)-Triapine in BEAS-2B Cells

William E Antholine  1 , Charles R Myers  2
Affiliations

Concentration of Fe(3+)-Triapine in BEAS-2B Cells

William E Antholine et al. Int J Mol Sci. .

Abstract

An electron paramagnetic resonance (EPR) method was used to determine the concentration of the antitumor agent Triapine in BEAS-2B cells when Triapine was bound to iron (Fe). Knowledge of the concentration of Fe-Triapine in tumor cells may be useful to adjust the administration of the drug or to adjust iron uptake in tumor cells. An EPR spectrum is obtained for Fe(3+)-Triapine, Fe(3+)(Tp)2+, in BEAS-2B cells after addition of Fe(3+)(Tp)2+. Detection of the low spin signal for Fe(3+)(Tp)2+ shows that the Fe(3+)(Tp)2+ complex is intact in these cells. It is proposed that Triapine acquires iron from transferrin in cells including tumor cells. Here, it is shown that iron from purified Fe-transferrin is transferred to Triapine after the addition of ascorbate. To our knowledge, this is the first time that the EPR method has been used to determine the concentration of an iron antitumor agent in cells.

Keywords: BEAS-2B bronchial epithelial cells; EPR; Triapine; electron paramagnetic resonance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic of FeTp2 designated Fe-Triapine. Reprinted with permission from Kowol, C.R.; Trondl, R.; Heffeter, P.; Arion, V.B.; Jukupec, M.A.; Roller, A., Galanski, M.; Berger, W.; Keppler, B.K. Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine) and novel insights into terminal dimethylation, J. Med. Chem., 2009, 52, 5032–5043, doi: 10.1021/jm900528d). Copyright 2009 American Chemical Society.
Figure 2
Figure 2
The electron paramagnetic resonance (EPR) spectra of BEAS-2B cells (6 × 107 cells/mL) treated with Fe(3+)(Tp)2+ (33 µM concentration in cells). Insert: The EPR signal for Fe(3+)(Tp)2+ at different concentrations. Spectrometer conditions, 5 G mod.; microwave freq., 9.633 GHz; 7 K; 25 scans; microwave power, 0.2 mW.
Figure 3
Figure 3
EPR spectrum for 80 µM FeTf with or without 30 µM Triapine (top spectrum) and FeTf plus Triapine plus ascorbate (bottom spectrum). The addition of ascorbic acid to FeTf in the presence of Triapine results in a decrease in the FeTf signal and the appearance of the FeT2+ signal.
Figure 4
Figure 4
Reaction of Fe(2+)-Triapine, Fe(2+)(Tp)2, with oxygen to generate superoxide (O2●−), H2O2, and hydroxyl radical. Bottom: Coupled reactions for thioredoxin reductase (TrxR), thioredoxin (Trx), thioredoxin-2 (Trx2), and perioxiredoxin-3 (Prx3). Note: red = reduced, ox = oxidized.
See this image and copyright information in PMC

References

    1. Kunos C.A., Waggoner S., von Gruenigen V., Eldermire E., Pink J., Dowlati A., Kinsella T.J. Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer. Clin. Cancer Res. 2010;16:1298–1306. doi: 10.1158/1078-0432.CCR-09-2469. - DOI - PMC - PubMed
    1. Kunos C.A., Radivoyevitch T., Waggoner S., Debernardo R., Zanotti K., Resnick K., Fusco N., Addams R., Redline R., Faulhaber P., et al. Radiochemotherapy plus 3-amino-2-caroxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers. Gynecol. Oncol. 2013;130:75–80. doi: 10.1016/j.ygyno.2013.04.019. - DOI - PMC - PubMed
    1. Richardson D.R. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol. Rev. 2005;57:547–583. doi: 10.1124/pr.57.4.2. - DOI - PubMed
    1. Kovacevic Z., Chikhani S., Lovejoy D.B., Richardson D.R. Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene1: a new strategy for the treatment of pancreatic cancer. Mol. Pharm. 2011;80:598–609. doi: 10.1124/mol.111.073627. - DOI - PubMed
    1. Richardson D.R., Kalinowski D.S., Richardson V., Sharpe P.C., Lovejoy D.B., Islam M., Bernhardt P.V. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and anti-proliferative agents: redox activity, iron complexation and characterization of their antitumor activity. J. Med. Chem. 2009;52:1459–1470. doi: 10.1021/jm801585u. - DOI - PubMed